A patient with alcoholic cirrhosis of the liver, portal hypertension with hepatic encephalopathy and spontaneous bacterial peritonitis (SBP) was admitted in an obtunded condition. Attempts at delineating the aetiology of the SBP using conventional cultures as well as automated systems were not successful. The use of non-anionic surfactant agents such as Tween 80-incorporated blood agar and Triton X treatment of the specimens facilitated the growth of Klebsiella pneumoniae from the ascitic fluid, which otherwise would have been concluded to represent culture-negative neutrocytic ascites. Thus, the use of the aforementioned agents could be explored in elucidating the aetiology of body cavity infections when conventional methods fail.
The use of non-anionic surfactant agents such as Tween 80 and Triton X have been described in isolating organisms from continuous ambulatory peritoneal dialysis (CAPD) fluids. [2, 3] However, their utility in facilitating the growth of pathogens in other body fluids has remained unexplored. This case exemplifies their potential application in isolating organisms from a case that otherwise would have been labelled as culture-negative neutrocytic ascites (CNNA).
Case Report
A 45-year-old alcoholic man, not on regular follow-up with the hospital, was admitted in October 2005 with drowsiness, altered sensorium and inability to answer questions appropriately over the past 48 h. On examination, he was found to be pale, dehydrated, febrile, icteric, confused and disoriented, with bilateral pedal oedema, and was haemodynamically stable. Examination of the respiratory system revealed decreased air entry at the bases with diffuse ronchi. Abdominal examination revealed free fluid with oedema of the abdominal wall.
A complete blood count, urine examination, chest radiograph as well as an abdominal ultrasound was performed. The free fluid (ascitic fluid) was aspirated under ultrasound guidance as he was febrile and sent for clinical pathology analysis and cultures. Two sets of blood cultures (each set consisting of an aerobic, an anaerobic and a fungal culture) were drawn over a 24 h period and the patient was administered piperacillin-tazobactam 4.5 gm eight hourly and ciprofloxacin intravenous (IV) 200 mg twice a day in addition to other supportive therapy, such as IV albumin supplementation and transfusion of blood products. The antibiotic regimen was changed to meropenem IV 1 gm thrice a day on the fourth day of admission based on lack of clinical improvement (persistent fever and no significant decrease in the ascitic fluid cell count). However, he developed features of acute tubular necrosis, progressed to metabolic acidosis, became hypotensive and was mechanically ventilated. He became comatose and died of sepsis and multiorgan failure 6 days after admission.
The patient had a haemoglobin of 7.1 gm%, total white blood cell (WBC) count of 30,600 cells/mm 3 , with neutrophilic leucocytosis and a shift to the left with toxic granulations and marked thrombocytopaenia (platelet count 40,000/mm 3 ). The ascitic fluid was yellow, hazy and showed a WBC count of 10,000 cells/mm 3 with a differential count of 95% neutrophils and 5% lymphocytes. The gram-stained smear showed few gram-negative bacilli set against a background of degenerated polymorphonuclear leucocytes.
Around 5 mL of the ascitic fluid was inoculated into an aerobic and anaerobic blood culture vial each (Becton Dickinson, Cockyesville, MD, USA) and the rest of the fluid was centrifuged at 1500 rpm for 10 min. The sediment was plated onto blood agar (5% sheep blood), chocolate agar, MacConkey agar, brain heart infusion agar and Sabouraud's dextrose agar. Additionally, the deposit was also inoculated onto blood agar with 2% Tween 80, which was prepared according the procedure described in the literature.
[1] Four smears were prepared for a gram stain, methylene blue stain, periodic acid-Schiff stain and Ziehl-Neelsen stain for acid fast bacilli. The remaining portion of the fluid was treated with two to three drops of TritonX-100 (BDH Poole, Dorset, UK) for 30 min and then centrifuged at 3000 rpm for 10 min. The deposit so obtained was inoculated onto a second set of agar plates as mentioned before, except the Tween 80 blood agar plate. This procedure has been described in the literature. [3] All pates were incubated at 37°C and 5-6% CO 2 for 48 h.
The plates inoculated with the untreated deposit failed to show any growth after 48 h of aerobic incubation. The Bactec vials inoculated with the ascitic fluid did not show any growth. The plates containing the Triton X treated material as well as the Tween 80-incorporated blood agar showed a growth of Klebsiella pneumoniae [ Figures 1 and 2] . A sparse growth of coagulase-negative staphylococci was also obtained on one of the plates and this was considered as a contaminant as the same was not seen on the smear. The blood cultures accompanying the ascitic fluid also showed a growth of K. pneumoniae. The isolates were susceptible to all third-and fourthgeneration cephalosporins, aminoglycosides (gentamicin, amikacin, netilmicin and tobramycin), quinolones (ciprofloxacin, ofloxacin, moxifloxacin and gatifloxacin),
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β-lactam-β-lactamase inhibitors (ticarcillin-clavulanic acid, piperacillin-tazobactam and cefoperazone-sulbactam) as well as the carbapenems (imipenem, meropenem and ertapenem) using the British Society for Antimicrobial Chemotherapy methodology for antimicrobial susceptibility testing. [4] 
Discussion
This was an alcoholic adult with cirrhosis of the liver, portal hypertension complicated by primary peritonitis and bacteraemia. It is common for ascitic fluid cultures to be sterile, even when the leucocyte counts are more than 500 cells/mm 3 . [5] This entity is called CNNA.
The use of Tween 80 and Triton-X has been previously reported in the processing of CAPD fluid. [2, 3] Both the aforementioned agents are 100% pure, self-sterilising, non-anionic surfactant agents. They yield a better growth of organisms as compared with direct plating methods. This could be achieved either by liberating intracellular bacteria before they are killed and/or separation of bacteria by a reduction in surface tension, thus allowing growth of more colony forming units on the primary and secondary inocula. The same holds true for the Tween 80-incorporated blood agar. This plate in addition allows for a more ready appreciation of contaminants and mixed cultures than methods based on enrichment broth as well as an earlier growth of pathogens. [3] Earlier studies have documented the use of these agents but in CAPD fluids alone [2, 3] and not for other body fluids. We report the use of these agents in processing the ascitic fluid from a case of SBP and hope that these results would pave the way for their use in other body fluids in the clinical laboratory. Direct plating techniques employed with ascitic fluid and other body fluids are frequent causes of culture-negative results and could categorise a sizeable number of our patients as suffering from CNNA. [6] CNNA, as diagnosed by standard criteria, [7] is a distinct clinical entity where cultures are sterile and, therefore, the antibiotic therapy is not guided by antimicrobial susceptibility test results. Supplementation of media (with Tween 80) or techniques (use of Triton X and inoculation of the treated specimen onto non-selective culture media) coupled with routine inoculation of blood culture vials will facilitate the isolation of organisms from body fluids (which would otherwise be reported as sterile) and help guide antimicrobial therapy in such patients. [8] A unique feature of this case is that we could obtain growth of K. pneumoniae only after using Triton X and Tween 80-incorporated blood agar as described above. While 5 mL of the fluid was inoculated into blood culture (BACTEC) vials, they did not yield a growth of organisms even at the end of the 7-day incubation at 37°C. The concentration at which Tween 80 is used is important as a higher concentration may prove toxic to bacteria. From our observations, it appears that body fluids with a rich neutrophilic infiltrate from patients with clinically suspected primary peritonitis may have sequestered organisms within neutrophils, which are available for culture only when they are released from their intracellular milieu. The cells remain aggregated and clumped together, leading to spuriously low or no viable counts on conventional media. Hence, it is important for clinical laboratories to make a concerted effort at increasing the isolation rates of organisms from body fluids using these agents. This helps in direct therapy of patients suffering from primary peritonitis. 
PULMONARY BOTRYOMYCOSIS IN A PATIENT WITH DOWN SYNDROME
Pulmonary botryomycosis is a rare chronic, pyogranulomatous infection affecting the lung parenchyma. We describe here the clinical and histopathological findings of pulmonary botryomycosis reported for the first time in a Down syndrome female who required prolonged intensive care. This case has other different unique aspects. It is the first case to present with empyema, the second case involving the right lower lobe and the first case managed by decortication.
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Botryomycosis was first described in a horse lung in 1870. [1] It is a rare chronic, pyogranulomatous infection caused mainly by Staphylococcus aureus and occasionally by other bacteria such as Pseudomonas aeruginosa, Proteus sp., Escherichia coli, Serratia marcescens, Neisseria sp., Moraxella sp., Propionibacterium sp. and others. [2] The term botryomycosis is derived from the Greek words botryose (bunch of grapes) and mycosis (fungus). [3] Histologically, the appearance consists of densely packed microorganisms surrounded by eosinophilic material and is similar to that of actinomycosis with characteristic granule formation. [4, 5] Two forms exist; a relatively common cutaneous form (75%) and a rare visceral one (25%). [3] The lung is rarely the primary location of this disease, with only 23 reported cases in the English literature. We describe here a case of pulmonary botryomycosis in a Down syndrome female. To our knowledge, this may be the first case of botryomycosis to be reported from Saudi Arabia or in a Down syndrome patient.
Case Report
A 23-year-old Saudi Down syndrome female presented to the emergency room on 29 January 2008 with a 1-month history of fever, productive cough and worsening dyspnea. She had received medical care at different centres without any improvement. There was no history of recent travel or exposure to sick contacts. Past medical history was unremarkable apart from being diagnosed with Down syndrome and cognitive developmental delay. Physical examination revealed a sick-looking, febrile (38.5ºC) female with tachypnea, tachycardia and hypotension. Oxygen saturation was 82% at room air. There was nearly absent breathing sounds over the right side of the chest. Chest radiograph revealed near total opacification of the right lung with hydropneumothorax, lung collapse and contralateral mediastinal shift [ Figure 1 ]. A chest computed tomography (CT) scan [ Figure 1 ] revealed right-sided massive loculated collection associated with air-fluid levels, complete collapse of the right lung and contralateral mediastinal shift. There was also an anterior mediastinal loculated collection compressing the great vessels. Intravenous fluids and piperacillintazobactam were administered immediately along with other supportive measures. Initial laboratory results showed a very high erythrocyte sedimentation rate (138 mm/h), elevated blood leukocytes (17.6 × 10 9 /L) and low haemoglobin (9 gm/ dL). She had low serum albumin (19 g/L) and elevated serum creatinine. The patient underwent immediate decortication (empyemectomy, multiple abscesses drainage, partial parietal pleurectomy and removal of the constricting peal) through the right posterolateral thoracotomy with lung isolation anaesthesia. The right lower lobe was found to be completely hepatized. Post-operatively, the patient required mechanical ventilation for 17 days and the antimicrobial regimens were modified to include vancomycin, meropenem and levofloxacin over variable periods due to persistent fever. The patient continued to improve clinically and a repeated chest CT scan [ Figure 1 ] showed dramatic improvement. She was discharged after 40 days from surgery and she completed another month of oral levofloxacin. Bacterial, mycobacterial and fungal cultures of pleura, pleural fluid, blood and sputum failed to show any growth. Histopathologic examination
